Top Markets
Coin of the day
VISEN Pharmaceuticals VISEN Pharmaceuticals

VISEN Pharmaceuticals

2561
Ранг среди акций #16898
VISEN Pharmaceuticals operates as an investment holding company, concentrating... VISEN Pharmaceuticals operates as an investment holding company, concentrating on the development and commercialization of endocrine treatments across mainland China, Hong Kong, and Taiwan. Their flagship product, Lonapegsomatropin, offers a once-weekly, long-acting growth hormone replacement designed for pediatric growth hormone deficiency. The company is also progressing other therapies, such as TransCon CNP (navepegritide), a long-acting prodrug utilizing c-type natriuretic peptide for achondroplasia, and Palopegteriparatide, a daily parathyroid hormone replacement therapy intended for chronic hypoparathyroidism. VISEN has forged strategic collaborations with Shanghai Pharmaceutical and United Family Healthcare. The enterprise was founded in 2018 and is based in Suzhou, China.
Цена акции
$2.46
Рыночная капитализация
$268.65M
Изменение (1 день)
-1.73%
Изменение (1 год)
-57.06%
Страна
CN
Торговля VISEN Pharmaceuticals (2561)

Категория

История цены акций VISEN Pharmaceuticals (2561)
Наивысшая цена закрытия: $2.49 2026-09-01

Наименьшая цена закрытия: $7.66 2025-03-01
История цены акций VISEN Pharmaceuticals с 2025 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -15.85%
2025 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$171.67 -
DE
$165.05 31.32%
DE
$38.13 25.43%
JP
$21.25 19.49%
IN
$214.66 25.92%
CH